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The specific numbers of patients and procedures that will 
be required to develop expertise in this discipline have not 
been well defined. It may be helpful to note that the several 
currently active multidisciplinary programs training clinicians 
in this area typically have well delineated populations of at 
least 500 adult patients, and have regularly scheduled clinics 
encompassing 10 to 20 patients/week, including diagnostic 
procedures. The level 2 trainee should be involved with the 
care of a minimum of 10 patients/week. 
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The application of the techniques of molecular biology to the 
study of the cardiovascular system has resulted in the creation of 
an enormous and growing new knowledge base of clinical as well 
as investigative r levance that demands a sufficient amount of 
time to master. It has now been shown that atherosclerotic 
plaques can be stabilized or even reversed, with a clinically 
significant impact on outcome. Because cardiologists provide 
most of the care for patients with symptomatic or advanced 
cardiovascular disease, it is imperative for cardiovascular special- 
ists to become proficient in the primary and secondary prevention 
of cardiovascular diseases. This also includes the ability of the 
cardiologist to identify patients at high risk for cardiovascular 
disease and to recommend specific primary preventive measures. 
A copy of the policy statement on preventive cardiology and 
atherosclerosis approved by the American College of Cardiology 
is appended. This report outlines pecific areas of knowledge 
necessary toachieve these goals. 
General Standards and Environment 
The training institution must have the appropriate facilities 
and staff to conduct a general training program in clinical 
cardiovascular medicine. Trainees and staff should have op- 
portunities for research in the basic biomedical science depart- 
ments of the training institution as well as in the cardiovascular 
division. It is desirable for this training to take place in an 
academic medical center or an institution with a strong com- 
mitment to academic training and appropriate certification. 
Trainees must meet he criteria required for admission to 
an adult cardiology training program and should have ade- 
quate preparation i the biologic, physical and epidemiologic 
sciences basic to medicine. 
The faculty of the institution must be adequate in number 
and experience to conduct a training program in clinical 
cardiovascular medicine. It is desirable for certain members of 
the faculty to have special expertise in vascular biology, 
atherosclerosis, hypertension, disorders of lipid metabolism, 
peripheral vascular disease, thrombosis, thrombolysis, preven- 
tive cardiology, clinical epidemiology and the clinical pharma- 
cology of cardiovascular d ugs (1). 
Content of the Training Program 
Knowledge in this field can be obtained at three levels. 
Level 1 
Level 1 includes training that should be part of the knowl- 
edge base of all clinical cardiologists and includes exposure to 
the following general and specific areas. 
General content areas: 
1. Vascular biology of the heart and blood vessels. (It is 
important for future cardiovascular medicine trainees to 
understand the language of molecular biology so as to 
continue self-study and critical review of published medical 
reports). 
2. Clinical epidemiology and biostatistics. 
3. Principles of clinical trials and outcomes research. 
4. Principles of clinical pharmacology. 
Exposure to the following specific content areas is also essen- 
tial: 
1. Diagnosis and treatment of primary and secondary hyper- 
tension. 
2. Diagnosis and treatment ofprimary and secondary dyslipi- 
demias. 
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3. Diagnosis and treatment of thrombosis and hypercoagu- 
lable states. 
4. Management of smoking cessation and nicotine addiction. 
5. Cardiac rehabilitation. 
6. Exercise physiology. 
7. Nutrition and its effects on the cardiovascular system. 
8. Psychosocial and behavioral aspects of cardiovascular dis- 
eases. 
9. Diagnosis and treatment of peripheral vascular disease (1). 
Training in these areas should be integrated into consulta- 
tive, inpatient and outpatient rotations and didactic compo- 
nents of core cardiovascular medicine programs. The time 
allotted should be equivalent to 1 month of full-time training. 
Alternatively, this goal could be met by 1 month of block time 
followed by experience in continuity clinics. 
Level 2 
Level 2 training should achieve a level of expertise for the 
cardiovascular specialist so that the trainee could serve as an 
independent consultant to other cardiovascular p actitioners in 
the management of cardiovascular risk factors. This should 
involve 6 to 12 months of training within the 36 months of a 
cardiovascular training program and include block time for direct 
evaluation of patients with advanced atherosclerosis, resistant 
hypertension or hyperlipidemia or recurrent thrombosis. 
This could involve block time in hypertension and lipid clinics 
or services, or both, coagulation laboratories, peripherial vascular 
laboratories, clinical and cardiac rehabilitation services and addi- 
tional exposure to behavioral medicine, exercise physiology, clin- 
ical epidemiology, outcomes research and vascular biology. 
The clinical application of information contributed by newly 
emerging fields, such as vascular biology and medicine, lends 
itself to the development of the clinician/scientist and the 
expert teacher/clinician. 
Level 3 
Level 3 requtres advanced training to qualify as a director of a 
clinical service or research program, or both. Examples include 
director of a preventive cardiology, hypertension or lipid service; 
director of a cardiac rehabilitation program; or director of a 
vascular biology laboratory; or a trainee who obtains an MPH in 
clinical epidemiology or outcomes research, or both. 
Training to this level would require at least 1 year of a 
36-month program. Alternatively, 2 to 3 years in a vascular 
biology laboratory or health services outcomes research/clinical 
epidemiology program would be required to attain expertise in 
these fields, possibly leading to an advanced egree. 
Evaluation 
The basic science knowledge and clinical competence of the 
trainees must be evaluated regularly by the cardiovascular 
medicine program director. The evaluation should include 
fund of knowledge; manual, clinical and decision making skills; 
and clinical judgment, attitude and relations. Trainees must be 
informed about the results of their evaluations. 
Appendix. Policy Statement 
Preventive Cardiology and Atherosclerotic Disease 
To fulfill its mission to foster "optimal cardiovascular disease 
prevention," it is appropriate and necessary that the American College 
of Cardiology develop a leadership role in preventive cardiology. In 
1980 Dr. Robert O. Brandenberg, College President, expanded that 
aspect of the mission statement asfollows: "The mission of the College 
is to ensure optimal care for persons with cardiovascular disease or the 
potential for developing it; and ultimately through education and 
socioeconomic a tivities to contribute significantly to the prevention of 
cardiovascular disease." 
With increasing knowledge concerning the specific roles of the 
various risk factors in atherosclerotic and thrombotic diseases and 
vascular dysfunction, strategies aimed at the appropriate detection and 
modification of these risk factors now demonstrate he potential for 
slowing the progress of atherosclerosis and even regressing the pro- 
cess. Recent data suggest an important reduction in adverse clinical 
sequelae in certain high risk groups. The results of clinical experiences, 
clinical trials and published consensus reports establish that outcomes 
can be improved by promoting favorable life-style behaviors and 
treating identified abnormalities. When interventions are appropri- 
ately targeted, there is little debate that they can be both clinically and 
cost-effective. Current legislative and social initiatives favor health 
policies based on the concept of "prevention." In contrast o the 
prevention of cardiac diseases, uch as rheumatic fever and infective 
endocarditis, it is unlikely that such measures truly prevent he 
development ofatherosclerotic disease, or the adverse vents resulting 
therefrom, although a reduction in disease incidence and severity is 
probable, and fewer complications can be expected in many patients. 
Therefore, this Committee recommends that the College reaffirm and 
expand its policies regarding prevention of cardiovascular diseases. 
The College will actively promote 1) dissemination of information 
relative to the prevention of atherosclerotic cardiovascular diseases 
and of its adverse consequences; 2) development of educational 
programs pecific to the role of the cardiovascular specialist with 
regard to prevention; 3) cooperative development of practice guide- 
lines, for consultative as well as rehabilitation services, to deliver 
cost-effective preventive care; 4) policies of fair reimbursement for 
effective services; 5) participation in the assessment of clinical out- 
comes of such programs. 
The College recommends that cardiovascular specialists also pro- 
mote preventive cardiac are by 1) endorsing antismoking policies and 
programs; 2) encouraging healthy dietary behavior by limitation of 
total calorie intake, fat and cholesterol; 3) promoting prudent physical 
activity; 4) ensuring adequate control of arterial blood pressure; 5) 
managing patients with hyperlipidemia and with metabolic, oagulative 
and other risk factors; 6) advising primary care physicians with regard 
to risk reduction; 7) developing a cardiovascular health promotion 
plan for cardiac patients and their families. 
These actions of the American College of Cardiology serve to define 
the opportunities and responsibilities of cardiovascular specialists. 
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